|
US7029702B2
(en)
*
|
1998-07-07 |
2006-04-18 |
Ritter Natural Sciences Llc |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
|
|
SE523771C2
(sv)
*
|
1999-05-21 |
2004-05-18 |
Probi Ab |
Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
|
|
DE60119515T2
(de)
*
|
2000-05-25 |
2007-05-24 |
Société des Produits Nestlé S.A. |
Probiotica für verwendung als haustierfutter
|
|
SE0003100D0
(sv)
|
2000-09-01 |
2000-09-01 |
Probi Ab |
New strains
|
|
SE0003576D0
(sv)
*
|
2000-10-04 |
2000-10-04 |
Probi Ab |
New strain
|
|
KR100419132B1
(ko)
*
|
2000-12-29 |
2004-02-18 |
조성근 |
위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:h7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이csk 01
|
|
SE0103695D0
(sv)
|
2001-11-07 |
2001-11-07 |
Thomas Boren |
A novel non-antibiotic strategy against OGIP infections based on a cereal product
|
|
WO2003080813A2
(en)
|
2002-03-21 |
2003-10-02 |
Bifodan A/S |
Lactobacillus strains
|
|
JP4308481B2
(ja)
*
|
2002-06-18 |
2009-08-05 |
独立行政法人農業・食品産業技術総合研究機構 |
抗アレルギー剤
|
|
DK1565547T4
(da)
|
2002-06-28 |
2013-01-14 |
Biosearch S A |
Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
|
|
EP1384483A1
(en)
*
|
2002-07-23 |
2004-01-28 |
Nestec S.A. |
Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
|
|
JP2004189672A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Gen Corp:Kk |
抗下痢症組成物
|
|
EP1759597B1
(en)
*
|
2003-03-13 |
2009-01-21 |
Kirin Holdings Kabushiki Kaisha |
Probiotic composition
|
|
WO2004087891A1
(en)
*
|
2003-04-02 |
2004-10-14 |
Axcan Pharma S.A. |
Lactobacillus fermentum strain and uses thereof
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
MY143693A
(en)
|
2004-03-24 |
2011-06-30 |
Nestec Sa |
Shelf stable product wih living micro-organisms
|
|
ITRM20040166A1
(it)
*
|
2004-03-31 |
2004-06-30 |
Alberto Cresci |
Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
|
|
WO2006012536A2
(en)
*
|
2004-07-22 |
2006-02-02 |
Ritter Andrew J |
Methods and compositions for treating lactose intolerance
|
|
TW200637908A
(en)
*
|
2005-01-04 |
2006-11-01 |
Calpis Co Ltd |
Method for preparation of lactic acid bacterium having anti-allergic activity
|
|
AU2006233918B2
(en)
|
2005-04-13 |
2012-06-21 |
Nestec S.A. |
Infant formula with probiotics
|
|
US20060263311A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Scavone Timothy A |
Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
|
|
EP2261323A1
(en)
|
2005-05-31 |
2010-12-15 |
The Iams Company |
Feline probiotic lactobacilli
|
|
AU2006253007B2
(en)
|
2005-05-31 |
2012-12-20 |
Alimentary Health Ltd |
Feline probiotic Bifidobacteria
|
|
WO2007040446A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Probi Ab |
Use of lactobacillus for treatment of autoimmune diseases
|
|
ES2381211T3
(es)
|
2006-02-15 |
2012-05-24 |
Nestec S.A. |
Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
|
|
RU2448720C2
(ru)
|
2006-03-07 |
2012-04-27 |
Нестек С.А. |
Синбиотическая смесь
|
|
DE502007004849D1
(de)
*
|
2007-02-02 |
2010-10-07 |
May Amadeus Alexander |
Produkt mit lebenden probiotischen Mikroorganismen
|
|
EP1974735A1
(en)
*
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Reduction of risk of diarrhoea
|
|
EP1974743A1
(en)
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Probiotics to Improve Gut Microbiota
|
|
CN101273737B
(zh)
*
|
2007-03-28 |
2011-08-24 |
哈尔滨正方科技有限公司 |
一种在常温下保持高活菌数的发酵乳饮料的制备方法
|
|
PL2173196T3
(pl)
*
|
2007-07-06 |
2011-06-30 |
Nutricia Nv |
Zastosowanie probiotyków i włókien w biegunce
|
|
US20090110663A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Halow George M |
Method for treatment of bowel disorders
|
|
EP2072052A1
(en)
|
2007-12-17 |
2009-06-24 |
Nestec S.A. |
Prevention of opportunistic infections in immune-compromised subjects
|
|
KR20100120169A
(ko)
|
2008-01-24 |
2010-11-12 |
네스텍 소시에테아노님 |
영양 성분을 담고 있는 캡슐 및 이 캡슐로부터 영양액을 전달하는 방법
|
|
ES2658837T3
(es)
|
2008-03-14 |
2018-03-12 |
Nestec S.A. |
Mezcla simbiótica
|
|
EP2127661A1
(en)
|
2008-05-27 |
2009-12-02 |
Nestec S.A. |
Probiotics to improve gut microbiotica
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
EP2293802A4
(en)
*
|
2008-06-25 |
2011-11-09 |
Ritter Pharmaceuticals Inc |
LACTOSE COMPOSITIONS HAVING REDUCED LACTOSE CONTENT
|
|
EP2147678A1
(en)
|
2008-07-21 |
2010-01-27 |
Nestec S.A. |
Probiotics to increase IgA secretion in infants born by caesarean section
|
|
EP2166083B1
(en)
*
|
2008-12-31 |
2010-12-22 |
Syngen biotech CO., LTD. |
Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof
|
|
US20100196341A1
(en)
*
|
2009-02-05 |
2010-08-05 |
Syngen Biotech Co., Ltd. |
Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
|
|
EP2400839B1
(en)
|
2009-02-24 |
2016-09-07 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
US10576110B2
(en)
*
|
2009-05-11 |
2020-03-03 |
Societe Des Produits Nestle S.A. |
Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
EP2509429A1
(en)
|
2009-12-08 |
2012-10-17 |
Nestec S.A. |
Infant formula with probiotics and milk fat globule membrane components
|
|
EP3202406A1
(en)
|
2010-04-28 |
2017-08-09 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
EP2510932A1
(en)
*
|
2011-04-15 |
2012-10-17 |
Nestec S.A. |
Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
|
|
DK2734049T3
(en)
|
2011-06-20 |
2018-07-30 |
Heinz Co Brands H J Llc |
PROBIOTIC COMPOSITIONS AND PROCEDURES
|
|
EP3351554B1
(en)
|
2012-06-18 |
2021-06-09 |
H.J. Heinz Company Brands LLC |
Gluten-related disorders
|
|
PL2994150T3
(pl)
|
2013-05-10 |
2019-09-30 |
H.J. Heinz Company Brands Llc |
Probiotyki i sposoby zastosowania
|
|
EP3940067A1
(en)
|
2014-12-05 |
2022-01-19 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2016183532A1
(en)
|
2015-05-13 |
2016-11-17 |
Synlogic, Inc. |
Bacteria engineered to treat a disease or disorder
|
|
SG11201704543XA
(en)
|
2014-12-05 |
2017-07-28 |
Synlogic Inc |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
US9688967B2
(en)
|
2014-12-05 |
2017-06-27 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
US20160206666A1
(en)
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
|
JP7095993B2
(ja)
|
2015-03-02 |
2022-07-05 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
消化管炎症低下および/または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
|
|
ES2881384T3
(es)
|
2015-05-13 |
2021-11-29 |
Synlogic Operating Co Inc |
Bacterias manipuladas para reducir la hiperfenilalaninemia
|
|
WO2016200614A2
(en)
|
2015-06-10 |
2016-12-15 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2016210373A2
(en)
|
2015-06-24 |
2016-12-29 |
Synlogic, Inc. |
Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
|
|
WO2016210378A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Multi-layered control of gene expression in genetically engineered bacteria
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
EP3328988A1
(en)
|
2015-07-31 |
2018-06-06 |
Synlogic, Inc. |
Bacteria engineered to treat disorders involving propionate catabolism
|
|
US11273184B2
(en)
|
2015-08-31 |
2022-03-15 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat disorders in which oxalate is detrimental
|
|
EP3368696A1
(en)
|
2015-10-30 |
2018-09-05 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
WO2017075485A1
(en)
|
2015-10-30 |
2017-05-04 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
|
|
US11685925B2
(en)
|
2015-10-30 |
2023-06-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
ES2925049T3
(es)
|
2015-11-16 |
2022-10-13 |
Synlogic Operating Co Inc |
Bacterias manipuladas para reducir la hiperfenilalaninemia
|
|
WO2017123418A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
WO2017123592A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat disorders associated with bile salts
|
|
EP3402498A1
(en)
|
2016-01-11 |
2018-11-21 |
Synlogic, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
WO2017123676A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
|
|
WO2017123610A2
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to detoxify deleterious molecules
|
|
EP3411051A2
(en)
|
2016-02-04 |
2018-12-12 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
WO2017136795A1
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with tryptophan metabolism
|
|
WO2017139708A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
|
|
WO2017139697A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
BR112018071271B1
(pt)
*
|
2016-05-11 |
2023-04-11 |
Chr. Hansen A/S |
Processo para a produção de um produto alimentício de armazenamento ambiente
|
|
BR112019013863A2
(pt)
|
2017-01-06 |
2020-03-03 |
Synlogic Operating Company, Inc. |
Micro-organismos programados para produzir moduladores imunes e terapêuticos anticâncer em células tumorais
|
|
US10941433B2
(en)
|
2017-06-15 |
2021-03-09 |
Iowa State University Research Foundation, Inc. |
Neurotransmitter transport in probiotics
|
|
CN111655841A
(zh)
|
2017-06-21 |
2020-09-11 |
同生运营公司 |
用于治疗紊乱的细菌
|
|
JP2020527025A
(ja)
|
2017-07-12 |
2020-09-03 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
腫瘍細胞において免疫モジュレーターおよび抗がん治療剤を産生するようにプログラムされた微生物
|
|
US20210130806A1
(en)
|
2017-11-03 |
2021-05-06 |
Synlogic Operating Company, Inc. |
Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
|
|
CN110960559B
(zh)
*
|
2018-09-30 |
2021-02-26 |
内蒙古伊利实业集团股份有限公司 |
用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
|
|
US11274275B2
(en)
|
2018-09-30 |
2022-03-15 |
Inner Mongolia Yili Industrial Group Co., Ltd. |
Lactobacillus paracasei ET-22 and use thereof
|
|
KR20220003030A
(ko)
|
2019-04-29 |
2022-01-07 |
신로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
|
|
US20230173066A1
(en)
|
2019-07-23 |
2023-06-08 |
Frieslandcampina Nederland B.V. |
Nutritional composition comprising milk fat and immunoglobulin
|
|
JP2022548785A
(ja)
|
2019-09-24 |
2022-11-21 |
プロラクタ バイオサイエンス,インコーポレイテッド |
炎症性疾患及び免疫疾患の治療のための組成物及び方法
|
|
MX2022007925A
(es)
|
2019-12-24 |
2022-09-29 |
Univ Iowa State Res Found Inc |
Control de histamina para promover la salud y controlar la enterocolitis usando composiciones probioticas y/o enzimas, que degrada histamina.
|
|
CN113355252A
(zh)
*
|
2020-03-06 |
2021-09-07 |
南京卫岗乳业有限公司 |
一种副干酪乳杆菌及其应用
|
|
BR112022018571A2
(pt)
|
2020-03-20 |
2022-11-01 |
Synlogic Operating Co Inc |
Microrganismos manipulados para reduzir a hiperfenilalaninemia
|
|
KR20230088680A
(ko)
|
2020-08-14 |
2023-06-20 |
프롤랙타 바이오사이언스, 인코포레이티드 |
박테리아 요법에 사용하기 위한 인간 모유 올리고당 조성물
|
|
EP4256039A2
(en)
|
2020-12-02 |
2023-10-11 |
Synlogic Operating Company, Inc. |
Engineered microorganisms
|
|
CN116847860A
(zh)
|
2020-12-31 |
2023-10-03 |
同生运营公司 |
经工程化以减轻高苯丙氨酸血症的微生物
|
|
CA3204530A1
(en)
|
2021-01-12 |
2022-07-21 |
Gregory Mckenzie |
Synbiotic treatment regimens
|
|
CN112625983B
(zh)
*
|
2021-03-05 |
2021-05-28 |
山东中科嘉亿生物工程有限公司 |
一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
|
|
CN112877260B
(zh)
*
|
2021-03-30 |
2022-08-09 |
江南大学 |
一株缓解泻剂结肠的副干酪乳杆菌及其应用
|
|
EP4323385A1
(en)
|
2021-04-13 |
2024-02-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to secrete active proteins
|
|
CN115671144A
(zh)
*
|
2021-07-26 |
2023-02-03 |
锦乔生物科技有限公司 |
使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
|
|
WO2023044479A1
(en)
|
2021-09-17 |
2023-03-23 |
Synlogic Operating Company, Inc. |
Methods for reducing hyperphenylalaninemia
|
|
WO2023245168A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
WO2023245171A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
CA3260270A1
(en)
|
2022-06-22 |
2023-12-28 |
Iowa State University Research Foundation, Inc. |
FIGHTING HISTAMINE TO PROMOTE HEALTH AND COMBAT ENTEROCOLITIS WITH PROBIOTIC COMPOUNDS
|
|
CA3260276A1
(en)
|
2022-06-23 |
2023-12-28 |
Michael James |
Genetically modified recombinant bacteria for treating diseases associated with methionine metabolism and associated methods of use
|
|
WO2024081768A1
(en)
|
2022-10-12 |
2024-04-18 |
Synlogic Operating Company, Inc. |
Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
|
|
EP4605522A1
(en)
|
2022-10-17 |
2025-08-27 |
Synlogic Operating Company, Inc. |
Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l- aminoacid deaminase for reducing hyperphenylalaninemia
|
|
WO2024129974A1
(en)
|
2022-12-14 |
2024-06-20 |
Synlogic Operating Company, Inc. |
Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
|
|
WO2024130119A2
(en)
|
2022-12-16 |
2024-06-20 |
Prolacta Bioscience, Inc. |
Synbiotic compositions for short chain fatty acid production
|
|
EP4647439A1
(en)
|
2024-05-09 |
2025-11-12 |
Alma Mater Studiorum - Università di Bologna |
Non-pathogenic bacteria for delivery of ptd-fusion proteins
|